For the Inventor, By the Inventor

Enter assignee name

Fremont, CA, United States of America

Ultima Genomics, Inc.

USPTO Granted Patents = 62

EPO Patents = 2

Trademarks = 3

Forward Citations = 308

Loading Chart...

Loading Chart...

42 inventors (with patents filed for the assignee):

Gilad Almogy (47 out of 128 patents)

Nathan Beckett (28 out of 70 patents)

Mark Pratt (23 out of 23 patents)

4. Florian Oberstrass (21 out of 24 patents)

5. Steven Menchen (16 out of 139 patents)

6. Kristopher Barbee (12 out of 26 patents)

7. Nathan Caswell (11 out of 11 patents)

8. Avishai Bartov (11 out of 28 patents)

9. Linda G Lee (10 out of 92 patents)

10. Denis Pristinski (10 out of 27 patents)

11. Dumitru Brinza (10 out of 17 patents)

12. Joseph Anthony (9 out of 9 patents)

13. Jacob A Wolf (8 out of 13 patents)

14. Jose Martin Sosa (8 out of 8 patents)

15. Abizar Lakdawalla (8 out of 9 patents)

Core Competencies:

Photonic Structure Substrates

Substrate Functionalization

Nucleic Acid Variants

RNA Sequencing

Analyte Detection

Sequencing Error Correction

Biological Sample Processing

Modified Polynucleotides

Optical Detection

Accelerated Sequencing

Controlled Environments

Paired End Sequences

62 patents: Sort by Forward Citations

1. 12753405 - METHODS FOR PREPARING A LIBRARY OF POLYNUCLEOTIDE MOLECULES (2026-10-06),

2. 12730072 - Systems and methods using photonic structure substrates (2026-09-08),

3. 12678822 - Methods and systems for substrate functionalization (2026-07-14),

4. 12674199 - METHODS OF SEQUENCING NUCLEIC ACID MOLECULES (2026-07-07),

5. 12637713 - METHODS AND SYSTEMS FOR PHASING SEQUENCING STRANDS AND LONG-RANGE SEQUENCING (2026-05-26),

6. 12571036 - Methods, devices, and systems for analyte detection and analysis (2026-03-10),

7. 12522867 - RNA SEQUENCING METHODS (2026-01-13),

8. 12482536 - METHODS FOR DETECTING NUCLEIC ACID VARIANTS (2025-11-25),

9. 12480938 - Methods and systems for analyte detection and analysis (2025-11-25),

10. 12437839 - Methods for detecting nucleic acid variants (2025-10-07),

11. 12397300 - Methods and systems for nucleic acid analysis (2025-08-26),

12. 12378600 - Linkers and methods for optical detection and sequencing (2025-08-05),

13. 12378593 - Nucleic acid clonal amplification and sequencing methods, systems, and kits (2025-08-05),

14. 12319959 - Methods for nucleic acid analysis (2025-06-03),

15. 12239980 - Implementing barriers for controlled environments during sample processing and detection (2025-03-04),

Company Overview

Ultima Genomics, Inc., based in Fremont, CA, specializes in advanced nucleic acid sequencing technologies. The company focuses on developing innovative solutions in areas such as photonic structure substrates and substrate functionalization, enhancing the capabilities of RNA sequencing and analyte detection. Their research encompasses sequencing error correction and biological sample processing, aiming to improve the accuracy and efficiency of genetic analysis. Ultima Genomics is dedicated to advancing the field of genomics through cutting-edge technology and methodologies.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

62 Patents

#42 in Fremont, CA

#1,369 in California

#5,848 in US

#11,779 in the World

Fremont, CA, United States of America

Ultima Genomics, Inc.

Forward Citations = 308

42 inventors:

Gilad Almogy (47 out of 128 patents)

Nathan Beckett (28 out of 70 patents)

Mark Pratt (23 out of 23 patents)

4. Florian Oberstrass (21 out of 24 patents)

5. Steven Menchen (16 out of 139 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Ultima Genomics, Inc.. Retrieved from https://idiyas.com/company/ultima-genomics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…